Maintenance of the hematopoietic stem cell pool in bone marrow niches by EVI1-regulated GPR56

Leukemia

Volumn 27, Issue 8, 2013, Pages 1637-1649

  Saito, Y ^a   Kaneda, K ^a   Suekane, A ^a   Ichihara, E ^a   Nakahata, S ^a   Yamakawa, N ^a   Nagai, K ^a   Mizuno, N ^b   Kogawa, K ^c   Miura, I ^d   Itoh, H ^b   Morishita, K ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

acute myeloid leukemia; EVI1; GPR56; hematopoietic stem cell; RhoA

Indexed keywords

G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 56; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRAL INTEGRATION SITE 1 TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD; BONE MARROW; CANCER GROWTH; CELL ADHESION; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; GROWTH RATE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; LIVER; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN; STEM CELL NICHE;

ANIMALS; APOPTOSIS; BINDING SITES; BONE MARROW; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; G0 PHASE; GENE EXPRESSION REGULATION, LEUKEMIC; HEMATOPOIETIC STEM CELLS; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENES; RECEPTORS, G-PROTEIN-COUPLED; STEM CELL NICHE; TRANSCRIPTION FACTORS;

EID: 84881479702     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.75     Document Type: Article

References (32)

1. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 2007; 25: 1315-1321. (Pubitemid 350076512)
2. Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood 2009; 114: 1150-1157.
3. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988; 54: 831-840.
4. Morishita K, Parganas E, William CL, Whittaker MH, Drabkin H, Oval J et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA. 1992; 89: 3937-3941.
5. Lugthart S, Grö schel S, Beverloo HB, Kayser S, Valk PJ, van Zelderen-Bhola SL et al. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol 2010; 28: 3890-3898.
6. Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003; 101: 837-845. (Pubitemid 36139348)
7. Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, Valk PJ et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 2008; 111: 4329-4337.
8. Groschel S, Lugthart S, Schlenk RF, Valk PJ, Eiwen K, Goudswaard C et al. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. J Clin Oncol 2010; 28: 2101-2107.
9. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617-1628. (Pubitemid 38528701)
10. Verhaak RG, Wouters BJ, Erpelinck CA, Abbas S, Beverloo HB, Lugthart S et al. Prediction of molecular subtype in acute myeloid leukemia based on gene expression profiling. Haematologica 2009; 94: 131-134.
11. Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 2011; 17: 1086-1093.
12. Yuasa H, Oike Y, Iwama A, Nishikata I, Sugiyama D, Perkins A et al. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression. EMBO J. 2005; 24: 1976-1987. (Pubitemid 40896169)
13. Goyama S, Yamamoto G, Shimabe M, Sato T, Ichikawa M, Ogawa S et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008; 3: 207-220.
14. Saito Y, Nakahata S, Yamakawa N, Kaneda K, Ichihara E, Suekane A et al. CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Leukemia 2011; 25: 921-931.
15. Yamakawa N, Kaneda K, Saito Y, Ichihara E, Morishita K. The increased expression of integrin a6 (ITGA6) enhances drug resistance in EVI1high leukemia. PLoS ONE 2012; 7: e30706.
16. Ichihara E, Kaneda K, Saito Y, Yamakawa N, Morishita K. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1high leukemia cells. BBRC 2011; 416: 239-245.
17. Piao X, Hill RS, Bodell A, Chang BS, Basel-Vanagaite L, Straussberg R et al. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004; 303: 2033-2036. (Pubitemid 38393281)
18. Li S, Jin Z, Koirala S, Bu L, Xu L, Hynes RO et al. GPR56 regulates pial basement membrane integrity and cortical lamination. J Neurosci 2008; 28: 5817-5826.
19. Koirala S, Jin Z, Piao X, Corfas G. GPR56-regulated granule cell adhesion is essential for rostral cerebellar development. J Neurosci 2009; 29: 7439-7449.
20. Iguchi T, Sakata K, Yoshizaki K, Tago K, Mizuno N, Itoh H. Orphan G proteincoupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway. J Biol Chem 2008; 283: 14469-14478.
21. Shashidhar S, Lorente G, Nagavarapu U, Nelson A, Kuo J, Cummins J et al. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005; 24: 1673-1682. (Pubitemid 40461124)
22. Xu L, Begum S, Hearn JD, Hynes RO. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 2006; 103: 9023-9028. (Pubitemid 43902526)
23. Ke N, Sundaram R, Liu G, Chionis J, Fan W, Rogers C et al. Orphan G proteincoupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 2007; 6: 1840-1850. (Pubitemid 46954061)
24. Terskikh AV, Easterday MC, Li L, Hood L, Kornblum HI, Geschwind DH et al. From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci USA 2001; 98: 7934-7939. (Pubitemid 32642665)
25. Yang FC, Atkinson SJ, Gu Y, Borneo JB, Roberts AW, Zheng Y et al. Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci USA 2001; 98: 5614-5618. (Pubitemid 32435690)
26. Cancelas JA, Lee AW, Prabhakar R, Stringer KF, Zheng Y, Williams DA. Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization. Nat Med 2005; 11: 886-891. (Pubitemid 41161122)
27. Gu Y, Filippi MD, Cancelas JA, Siefring JE, Williams EP, Jasti AC et al. Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science 2003; 302: 445-449. (Pubitemid 37296270)
28. Ghiaur G, Lee A, Bailey J, Cancelas JA, Zheng Y, Williams DA. Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment. Blood 2006; 108: 2087-2094. (Pubitemid 44395025)
29. Yang L, Wang L, Geiger H, Cancelas JA, Mo J, Zheng Y. Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow. Proc Natl Acad Sci USA 2007; 104: 5091-5096. (Pubitemid 47186181)
30. Ghiaur G, Ferkowicz MJ, Milsom MD, Bailey J, Witte D, Cancelas JA et al. Rac1 is essential for intraembryonic hematopoiesis and for the initial seeding of fetal liver with definitive hematopoietic progenitor cells. Blood 2008; 111: 3313-3321.
31. Luo R, Jeong SJ, Jin Z, Strokes N, Li S, Piao X. G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination. Proc Natl Acad Sci USA 2011; 108: 12925-12930.
32. Xu H, Eleswarapu S, Geiger H, Szczur K, Daria D, Zheng Y et al. Loss of Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential. Blood 2009; 114: 3557-3566.